Keros Therapeutics KROS
NASDAQ KROS
$9.54 +0.21 (+2.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Keros Therapeutics (KROS) Tax Rate (2025 - 2026)

Updated

Keros Therapeutics (KROS) recorded Tax Rate of 6.06% in Q4 2025, up 6.72 percentage points from -0.66% a year earlier but down 10.30 percentage points from the prior quarter.

Analysis

Keros Therapeutics (KROS) Tax Rate (2025 - 2026) Analysis & Trends

For FY2025, Keros Therapeutics reported Tax Rate of 5.31%, up 5.47 percentage points from FY2024.

  • Annual Tax Rate has a five-year change of +4.94 percentage points (FY2020 to FY2025).
  • Across earlier years, Tax Rate came in at -0.16% in FY2024 and -3.54% in FY2021 (-3.92 pp).
  • Quarterly Tax Rate has ranged from -40.46% in Q4 2021 to 16.36% in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 16.36% (Q3 2025), 6.75% (Q2 2025) and 6.34% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 23.26%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 12.61%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 8.85%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.54%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 20.70%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.96%
10 Keros Therapeutics 185.02 Mn -900.96 Mn - 5.17%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.17%
Mar 31, 2025 6.34%
API Access

Keros Therapeutics Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=KROS&period=max&api_key=YOUR_API_KEY